Mahito Fukui
Director/Board Member at C&O Pharmaceutical Technology (Holdings) Ltd.
Profile
Mahito Fukui is currently an Executive Director at C&O Pharmaceutical Technology (Holdings) Ltd.
He completed his undergraduate and graduate degrees at Kwansei Gakuin University in 1995 and 1997 respectively.
He also obtained an MBA from Aoyama Gakuin University in 2005.
Mahito Fukui active positions
| Companies | Position | Start |
|---|---|---|
C&O Pharmaceutical Technology (Holdings) Ltd.
 C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Director/Board Member | 28/02/2019 |
Training of Mahito Fukui
| Kwansei Gakuin University | Undergraduate Degree |
| Aoyama Gakuin University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
C&O Pharmaceutical Technology (Holdings) Ltd.
C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Health Technology |
- Stock Market
- Insiders
- Mahito Fukui